Riskpilot← Back to searchSign inGet full accessGrandLeaf AB
ABActiveOrg 5568543226Ölöv 1630Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20110 employees
Revenue 2024
SEK 314K
-38% vs 2023
EBITDA margin
31.6%
-59% vs 2023
Equity ratio
-303630.9%
Financial strength
Net profit 2024
SEK 99K
-59% vs 2023
| Revenue | SEK 314K | -38% |
| EBITDA | SEK 99K | -59% |
| Net profit | SEK 99K | -59% |
| Total assets | SEK 444 | -95% |
| Equity | SEK -1,3M | +8% |
| Employees | 0 | — |
Legal name
GrandLeaf AB
Org number
5568543226
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
27 maj 2011
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget skall bedriva handel av livsmedel och hälsoprodukter såsom essensoljor, te och magnesium, äga och förvalta fastigheter, aktier och andelar och därmed förenlig verksamhet.
Address
Ölöv 1630
Email
mykivra@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 82 | 152 | 508 | 314 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −23 | 1 670 | 164 | 243 | 99 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −23 | 1 670 | 164 | 243 | 99 |
| Net financials | −11 | — | 1 | −0 | −0 |
| Profit before tax | −34 | 1 670 | 165 | 242 | 99 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −34 | 1 670 | 165 | 242 | 99 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11 | 26 | 2 | 8 | 0 |
| Equity | −3 541 | −1 871 | −1 706 | −1 463 | −1 348 |
| Long-term debt | 1 573 | 1 644 | — | — | — |
| Short-term debt | 1 979 | 252 | 1 708 | 1 472 | 1 349 |
| Total debt | 3 552 | 1 896 | 1 708 | 1 472 | 1 349 |
EBITDA margin
31.6%
This company
15.8%
Market median
+100% vs market
20202024
Equity ratio
-303630.9%
This company
38.2%
Market median
-794945% vs market
20202024
Return on equity
9897300.0%
This company
18.4%
Market median
+53789574% vs market
20202024
Net profit margin
31.5%
This company
8.1%
Market median
+289% vs market
20202024
Asset turnover
707.43×
This company
1.12×
Market median
+63063% vs market
20202024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GrandLeaf AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olivia Anna Sofia Wahlberg | Deputy Board Member | 0 companies |
| Maggie Natalie Wahlberg | Board of Directors | 0 companies |